CDC advisors to vote on COVID Omicron vaccines on Sept. 1
bymuratdeniz         

The CDC's Advisory Committee on Immunization Practices will meet on Thursday to discuss Moderna (NASDAQ:MRNA) and Pfizer (NYSE:PFE)/BioNTech's (NASDAQ:BNTX) bivalent COVID-19 vaccines that provide protection against Omicron subvariants.
The U.S. FDA is expected to provide Emergency Use Authorization for the shots as early as today.
The companies submitted applications for the new vaccines based on animal data primarily as human testing is not yet completed.
The Biden administration has previously said it wants a rollout of the new vaccines shortly after Labor Day.